康惠股份 (603139.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−15.3x

Market Cap

CNY 3.61B

MomentumView details →

1D Return

−2.75%

YTD Return

+78.60%

RSI (14)

53.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−15.3x

Market Cap

CNY 3.61B

RSI (14)

53.0

MomentumView details →

1D Return

−2.75%

YTD Return

+78.60%

ProfitabilityView details →

Gross Margin

27.40%

Net Margin

−66.62%

EBITDA Margin

−62.47%

ROE (TTM)

−54.11%

ROA (TTM)

−17.32%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

−20.22%

EPS YoY

—

FCF YoY

+79.19%

Revenue CAGR 3Y

−1.39%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.68x

Current Ratio

0.63x

Quick Ratio

0.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

+5.71%

Financials snapshotView financials →

Revenue (TTM)

443.29M

Net Income (TTM)

−295.33M

Op. CF (TTM)

32.38M

Latest newsMore news →

Shanghai Chuangxiangying Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5% of Kanghui Co., completed its share reduction plan, selling 998,800 shares via centralized bidding from July 16 to August 31, 2026, reducing its stake from above 5% to 4.69%.3d ago

Kanghui Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 9.0925 million yuan, turning from a loss in the same period of 2025.7d ago

Similar companies

威尔药业603351.SH Regencell Bioscience Holdings LimitedRGC 司太立603520.SH 灵康药业603669.SH Shandong Xinhua Pharmaceutical Company Limited00719.HK 卫信康603676.SH Find similar companies →

Latest newsMore news →

Shanghai Chuangxiangying Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5% of Kanghui Co., completed its share reduction plan, selling 998,800 shares via centralized bidding from July 16 to August 31, 2026, reducing its stake from above 5% to 4.69%.3d ago Kanghui Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 9.0925 million yuan, turning from a loss in the same period of 2025.7d ago